Evidence map›Paper›PMID 29721109›Full record

ReviewJournal of arrhythmia2018

Arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) in clinical practice.

Ka Hou Christien Li, George Bazoukis, Tong Liu, Guangping Li, William K K Wu, Sunny Hei Wong, Wing Tak Wong, Yat Sun Chan, Martin C S Wong, Katharina Wassilew and 2 more

Open access · goldAbstract readReview
In one paragraph

Review in Journal of arrhythmia, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.3field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Sudden cardiac death in the adolescent population: a narrative review.The Egyptian journal of internal medicine · 2023
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 5 countries.

Ka Hou Christien LiFaculty of Medicine Newcastle University Newcastle UK.
George BazoukisSecond Department of Cardiology Laboratory of Cardiac Electrophysiology "Evangelismos" General Hospital of Athens Athens Greece.ORCID 0000-0003-1009-9772
Tong LiuTianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular disease Department of Cardiology Tianjin Institute of Cardiology Second Hospital of Tianjin Medical University Tianjin China.
Guangping LiTianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular disease Department of Cardiology Tianjin Institute of Cardiology Second Hospital of Tianjin Medical University Tianjin China.
William K K WuDepartment of Anaesthesia and Intensive Care Faculty of Medicine Chinese University of Hong Kong Hong Kong China.
Sunny Hei WongLi Ka Shing Institute of Health Sciences Faculty of Medicine Chinese University of Hong Kong Hong Kong China.
Wing Tak WongSchool of Life Sciences Chinese University of Hong Kong Hong Kong China.
Yat Sun ChanDepartment of Medicine and Therapeutics Faculty of Medicine Chinese University of Hong Kong Hong Kong China.
Martin C S WongThe Jockey Club School of Public Health and Primary Care Faculty of Medicine The Chinese University of Hong Kong Hong Kong China.
Katharina WassilewDepartment of Pathology Rigshospitalet University Hospital of Copenhagen Copenhagen Denmark.
Vassilios S VassiliouNorwich Medical School University of East Anglia Norwich UK.
Gary TseLi Ka Shing Institute of Health Sciences Faculty of Medicine Chinese University of Hong Kong Hong Kong China.ORCID 0000-0001-5510-1253
Chinese University of Hong Kong · HKSecond Hospital of Tianjin Medical University · CNCopenhagen University Hospital · DKEvangelismos Hospital · GRNewcastle University · GBUniversity of East Anglia · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) is an inherited myocardial disease characterized by fibro-fatty replacement of the right ventricular myocardium, and associated with paroxysmal ventricular arrhythmias and sudden cardiac death (SCD). It is currently the second most common cause of SCD after hypertrophic cardiomyopathy in young people <35 years of age, causing up to 20% of deaths in this patient population. This condition has a male preponderance and is more commonly found in individuals of Italian and Greek descent. To date, there is no single diagnostic test for ARVC/D and the diagnosis is made based on clinical, electrocardiographic, and radiological findings according to the Revised 2010 Task Force Criteria. In this review, we will discuss the mainstay treatment which includes pharmacotherapy, implantable cardioverter-defibrillator insertion for abortion of sudden cardiac death, and in the advanced stages of the disease cardiac transplantation.

Indexed as

arrhythmogenic right ventricular cardiomyopathyarrhythmogenic right ventricular dysplasia

Identifiers

PMID29721109
PMCPMC5828272
OpenAlexW2792864313

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.